VR-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple Sclerosis

T

Tel Aviv Sourasky Medical Center

Status

Completed

Conditions

Multiple Sclerosis

Treatments

Behavioral: Treadmill training
Behavioral: Treadmill training with Virtual Reality

Study type

Interventional

Funder types

Other

Identifiers

NCT02427997
TASMC-15-NG-063-CTIL

Details and patient eligibility

About

A prospective, randomized controlled single-blind trial will test the hypotheses that a 6- week intervention that combines treadmill training (TT) with virtual reality (VR) significantly improves real-life, functional mobility and cognitive abilities, keys to health-related quality of life in patients with MS.

Full description

A prospective, single blinded,randomized controlled trial with 6 month follow-up will be employed to investigate the effects of treadmill training augmented with virtual reality on patients with MS. The study will include 200 participants. Participants will be randomized to either the intervention or active comparator. The intervention group will receive 18 sessions of Treadmill Training with Virtual Reality (TT+VR) and the active control comparison will receive 18 training sessions of treadmill training alone (TT) without the VR simulation All interventions will be delivered by therapists trained in the standard protocols. All subjects will be trained 3 times a week for 6 weeks, each session will last approximately 45 minutes.Training progression will be based on increasing both motor and cognitive challenges, individualized to the participant's level of performance.

Enrollment

139 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients will be included if:

  • They are between 18-65 years of age.
  • They have a confirmed diagnosis of relapsing remitting MS.
  • They have a score between 2 and 6 on the Expanded Disability Status Scale (EDSS)
  • They are free from dementia as determined using the Mini Mental State Exam (MMSE>=24)
  • They can walk on the treadmill without partial body weight support harness for 5 minutes at their preferred walking speed; this is set as the smallest bout length at the start of training.
  • They have no history of epileptic seizures.
  • They have no MS exacerbation within the preceding 4 weeks, as determined by interview and medical notes review.
  • They have stable MS disease treatments (e.g., last intake of steroids occurred at least 50 days before the enrolment, MS-specific drugs stable from at least 3 months, symptomatic drugs stable from at least 1 month before the enrolment).
  • They have adequate hearing (as evaluated by the whisper test and adequate vision capabilities (as measured using a Snellen chart, 6.20 cut-off).
  • They are willing to commit to treadmill training program week and participate in all of the assessments.
  • They provide informed written consent and are willing to be randomized to any of the 2 study arms.

Exclusion criteria

Patients will be excluded if:

  • They cannot follow safety or training instructions.
  • They have another neurological disorder, unstable cardiovascular disease, diabetes, lower limb arthritis, acute lower back or lower extremity pain, peripheral neuropathy, rheumatic or severe orthopaedic problems that may interfere with walking, or have diagnosed psychiatric problems.
  • They are pregnant.
  • They are undergoing any experimental drug or other kind of therapy.
  • Their medication regime is likely to change during the course of the study.
  • They are already participating in an intensive exercise program. The use of walking aids will not exclude participation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

139 participants in 2 patient groups

Treadmill training with virtual reality
Experimental group
Description:
The TT+VR patients (i.e., the experimental arm) will receive 18 sessions (3 times per week x 6 weeks) of training that will consist of walking on a treadmill while wearing a safety harness (without body weight support, recall Figure 1), and while being provided with feedback from the system.
Treatment:
Behavioral: Treadmill training with Virtual Reality
Treadmill training alone
Active Comparator group
Description:
TT alone will receive conventional treadmill training with no feedback from the system. They will train with a safety harness 18 sessions (3 times per week x 6 weeks).
Treatment:
Behavioral: Treadmill training

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems